middle.news
Ceryvyn Therapeutics Advances LAM Program with New Patent and Advisory Board
9:55am on Monday 27th of July, 2026 AEST
•
Biotechnology
Read Story
Ceryvyn Therapeutics Advances LAM Program with New Patent and Advisory Board
9:55am on Monday 27th of July, 2026 AEST
Key Points
Trading reinstated on ASX with new ticker CYV
Stage 1 preclinical nebulisation studies for CYV-101 underway
New US provisional patent filed on nebulised VEGF inhibitors
Scientific Advisory Board formed with global LAM experts
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ceryvyn Therapeutics (ASX:CYV)
OPEN ARTICLE